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MicroRNAs are regulated by gene alteration at the DNA
level, transcriptional regulation, and mature miRNA
processing via Dicer. Thus far, few studies have simultane-
ously assessed all three levels of regulation. Using real-
time quantitative polymerase chain reaction (QPCR)-
based arrays, changes in gene copy number, pre-miRNA
and mature miRNA levels for a large set of primary effu-
sion lymphomas (PELs) and primary Kaposi Sarcoma
biopsies (KS) has been determined; this includes miRNA
gene alterations and concordant changes in pre-miRNA
and mature miRNA expression levels. The real-time QPCR
based approach confirmed many of the KSHV viral and
cellular miRNAs previously cloned from PEL. However,
array-based profiling also uncovered many novel PEL-spe-
cific miRNAs, since cloning-based approaches are not
always saturating. The miRNA expression pattern for nei-
ther viral nor cellular miRNAs has hitherto been deter-
mined for KS. Furthermore, comprehensive SNP analysis
of the viral miRNAs has been profiled to further examine
the effects of sequence and processing. This defines the
miRNA signature of PEL, KS, KSHV-infected cancers and
experimental models. It shows that the transcriptional
regulation of pre-miRNA as well as mature miRNA levels
contribute non-redundant information that can be used
in the classification of human tumors.
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